Rising Genital Herpes Cases in England: Asymptomatic Spread and Stigma Persist

Context mode is active. Hover over any highlighted term to see its definition. Click a nested term to go deeper.
England is grappling with a concerning uptick in first-episode genital herpes diagnoses, which surged by 3.1% to 28,779 cases in 2025, according to the latest UK Health Security Agency (UKHSA) report released earlier this month. This increase stands in stark contrast to an 8.3% overall decline in other sexually transmitted infections (STIs) across the nation during the same period, underscoring persistent public health challenges beyond overall infection rates. Experts point to the insidious nature of asymptomatic viral shedding and deeply entrenched social stigma as key drivers, allowing the highly contagious virus to spread often undetected. The disproportionate rise in herpes cases illuminates critical vulnerabilities within England sexual health landscape, particularly as overall STI testing numbers, including for chlamydia among young women aged 15-24, also saw a notable decrease in 2025. This backdrop of reduced screening, coupled with significant real-terms cuts to local authority Public Health Grant funding for NHS Sexual Health Services since 2014, creates a perfect storm where latent infections can proliferate. Meanwhile, despite advancements in suppressive therapy using antivirals like Aciclovir and Valaciclovir, awareness gaps and persistent social stigma continue to deter individuals, especially Gen Z, from seeking timely diagnosis and care, thereby perpetuating transmission cycles. Moving forward, the UKHSA and health charities are pressing for enhanced awareness campaigns that directly confront the stigma associated with Genital Herpes, aiming to destigmatize testing and open dialogue, particularly among younger demographics. Addressing the fragmentation and under-resourcing of NHS Sexual Health Services remains paramount, with calls for a coherent national strategy and sustainable funding to bolster infrastructure and improve access. The effectiveness of these interventions will be crucial in mitigating the ongoing spread of a common, yet often silently transmitted, infection and reversing this troubling trend in England public health narrative.